Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrest
Richard J Mills,Drew M Titmarsh,Xaver Koenig,Benjamin L Parker,James G Ryall,Gregory A Quaife-Ryan,Holly K Voges,Mark P Hodson,Charles Ferguson,Lauren Drowley,Alleyn T Plowright,Elise J Needham,Qing-Dong Wang,Paul Gregorevic,Mei Xin,Walter G Thomas,Robert G Parton,Lars K Nielsen,Bradley S Launikonis,David E James,David A Elliott,Enzo R Porrello,James E Hudson,Richard J. Mills,Drew M. Titmarsh,Benjamin L. Parker,James G. Ryall,Gregory A. Quaife-Ryan,Holly K. Voges,Mark P. Hodson,Alleyn T. Plowright,Elise J. Needham,Walter G. Thomas,Robert G. Parton,Lars K. Nielsen,Bradley S. Launikonis,David E. James,David A. Elliott,Enzo R. Porrello,James E. Hudson
DOI: https://doi.org/10.1073/pnas.1707316114
IF: 11.1
2017-09-15
Proceedings of the National Academy of Sciences
Abstract:Significance Engineered cardiac muscle can be used to promote the structural and functional maturation of human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs). However, previous studies have not yet produced cardiac tissues with metabolic and proliferative maturation. Here, we develop a 96-well screening platform and screen for cardiac maturation conditions in engineered cardiac muscle. We found that simulating the postnatal switch in metabolic substrates from carbohydrates to fatty acids promoted a switch in metabolism, DNA damage response, and cell cycle arrest in hPSC-CM. Our study shows that this mechanism can be harnessed to enhance the maturation of human hPSC-CM and cardiac tissues, which has major implications for stem cell sciences, drug discovery, and regenerative medicine.